Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia
- PMID: 21295197
- PMCID: PMC3064506
- DOI: 10.1016/j.amjmed.2010.08.019
Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia
Abstract
Background: Community-acquired pneumonia is the most common infectious cause of death in the US. Over the last 2 decades, patient characteristics and clinical care have changed. To understand the impact of these changes, we quantified incidence and mortality trends among elderly adults.
Methods: We used Medicare claims to identify episodes of pneumonia, based on a validated combination of diagnosis codes. Comorbidities were ascertained using the diagnosis codes located on a 1-year look back. Trends in patient characteristics and site of care were compared. The association between year of pneumonia episode and 30-day mortality was then evaluated by logistic regression, with adjustment for age, sex, and comorbidities.
Results: We identified 2,654,955 cases of pneumonia from 1987-2005. During this period, the proportion treated as inpatients decreased, the proportion aged ≥80 years increased, and the frequency of many comorbidities rose. Adjusted incidence increased to 3096 episodes per 100,000 population in 1999, with some decrease thereafter. Age/sex-adjusted mortality decreased from 13.5% to 9.7%, a relative reduction of 28.1%. Compared with 1987, the risk of mortality decreased through 2005 (adjusted odds ratio, 0.46; 95% confidence interval, 0.44-0.47). This result was robust to a restriction on comorbid diagnoses assessing for the results' sensitivity to increased coding.
Conclusions: These findings show a marked mortality reduction over time in community-acquired pneumonia patients. We hypothesize that increased pneumococcal and influenza vaccination rates as well as wider use of guideline-concordant antibiotics explain a large portion of this trend.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.Circulation. 2012 Feb 14;125(6):773-81. doi: 10.1161/CIRCULATIONAHA.111.040766. Epub 2012 Jan 4. Circulation. 2012. PMID: 22219349
-
Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia.BMC Infect Dis. 2018 Apr 24;18(1):192. doi: 10.1186/s12879-018-3098-5. BMC Infect Dis. 2018. PMID: 29699493 Free PMC article.
-
Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.Clin Infect Dis. 2006 Apr 15;42(8):1093-101. doi: 10.1086/501354. Epub 2006 Mar 13. Clin Infect Dis. 2006. PMID: 16575726
-
Pediatric Community-Acquired Pneumonia in the United States: Changing Epidemiology, Diagnostic and Therapeutic Challenges, and Areas for Future Research.Infect Dis Clin North Am. 2018 Mar;32(1):47-63. doi: 10.1016/j.idc.2017.11.002. Epub 2017 Dec 18. Infect Dis Clin North Am. 2018. PMID: 29269189 Free PMC article. Review.
-
Improving outcomes of elderly patients with community-acquired pneumonia.Drugs Aging. 2008;25(7):585-610. doi: 10.2165/00002512-200825070-00005. Drugs Aging. 2008. PMID: 18582147 Review.
Cited by
-
Pre-COVID-19 hospital quality and hospital response to COVID-19: examining associations between risk-adjusted mortality for patients hospitalised with COVID-19 and pre-COVID-19 hospital quality.BMJ Open. 2024 Mar 29;14(3):e077394. doi: 10.1136/bmjopen-2023-077394. BMJ Open. 2024. PMID: 38553067 Free PMC article.
-
Incidence, recurring admissions and mortality of severe bacterial infections and sepsis over a 22-year period in the population-based HUNT study.PLoS One. 2022 Jul 12;17(7):e0271263. doi: 10.1371/journal.pone.0271263. eCollection 2022. PLoS One. 2022. PMID: 35819970 Free PMC article.
-
The hospitalization burden of all-cause pneumonia in China: A population-based study, 2009-2017.Lancet Reg Health West Pac. 2022 Apr 6;22:100443. doi: 10.1016/j.lanwpc.2022.100443. eCollection 2022 May. Lancet Reg Health West Pac. 2022. PMID: 35400017 Free PMC article.
-
Can Electronic Decision Support Tools Really Reduce Mortality from Community-acquired Pneumonia?Am J Respir Crit Care Med. 2022 Jun 1;205(11):1267-1268. doi: 10.1164/rccm.202202-0358ED. Am J Respir Crit Care Med. 2022. PMID: 35320063 Free PMC article. No abstract available.
-
The Relative Ability of Comorbidity Ascertainment Methodologies to Predict In-Hospital Mortality Among Hospitalized Community-acquired Pneumonia Patients.Med Care. 2018 Nov;56(11):950-955. doi: 10.1097/MLR.0000000000000989. Med Care. 2018. PMID: 30234766 Free PMC article.
References
-
- Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 Jan 23;336(4):243–250. - PubMed
-
- Fry AM, Shay DK, Holman RC, Curns AT, Anderson LJ. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002. Jama. 2005 Dec 7;294(21):2712–2719. - PubMed
-
- Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sorensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care. 2007 Sep;30(9):2251–2257. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
